Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma

BACKGROUND: Currently, systemic therapies for patients with advanced-stage hepatocellular carcinoma (HCC) rely mainly on systemic drugs. However, traditional systemic drugs have a high rate of serious adverse events, and the curative effects of some potential anticancer drugs, such as curcumin (CUR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yongshun, Jia, Ran, Li, Jun, Tian, Xiaohe, Qian, Yeben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301856/
https://www.ncbi.nlm.nih.gov/pubmed/35858935
http://dx.doi.org/10.1186/s12951-022-01554-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301856/
https://www.ncbi.nlm.nih.gov/pubmed/35858935
http://dx.doi.org/10.1186/s12951-022-01554-y

Ejemplares similares